Manufactures polyurethane chemicals, including methyl diphenyl diisocyanate and polyols. Produces performance products such as amines and maleic anhydrides. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 0.3× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 69% of them.
Analysts' average target sits 29% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly below the class average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
An investor who bought at the very peak is down 77% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
It pays out $0.51 per share each year — regular cash for whoever holds the stock.
A loss of $275M against $5.7B in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 1.6 years. After that, the company needs to find new money.
On our five-subject report card, HUN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: HUN’s sales are going backwards, and it closed last year at a loss. The road back runs through both.